This inventor holds 1 USPTO granted patent. Top assignee: The Wistar Institute. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Mark Nesbit: Innovator in Vascular Development and Wound Repair
Introduction
Mark Nesbit is a notable inventor based in Palmyra, NJ (US). He has made significant contributions to the field of biomedical engineering, particularly in methods for enhancing wound repair and vascular development in mammalian tissue.
Latest Patents
Mark Nesbit holds a patent for "Methods for inducing localized vascular development and enhancing the repair of a wound in the mammalian dermis." This innovative method focuses on repairing defects and inducing vascularization in mammalian tissue, especially skin. The process involves administering a recombinant replication-defective virus, preferably adenovirus, that carries a selected growth factor gene, such as VEGF or PDGF. This method is designed to enhance the expression of growth factors, thereby improving tissue repair. Additionally, it includes a technique for infecting transplant tissues with recombinant adenoviruses prior to transplantation, as well as screening methods for treating angiogenic disorders like hemangiomas and cancers.
Career Highlights
Mark Nesbit is affiliated with The Wistar Institute of Anatomy & Biology, where he has been instrumental in advancing research in tissue engineering and regenerative medicine. His work has paved the way for new therapeutic approaches in treating various medical conditions.
Collaborations
Mark has collaborated with esteemed colleagues such as Meenhard Herlyn and Kapaettu Satyamoorthy, contributing to a rich environment of innovation and research.
Conclusion
Mark Nesbit's contributions to the field of vascular development and wound repair highlight his role as a leading inventor in biomedical engineering. His innovative methods and collaborative efforts continue to influence advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
